These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Aberrant gray matter volume and functional connectivity in Parkinson's disease with minor hallucination. Zhong M; Li C; Lu H; Xue D; Wang Y; Jiang Y; Zhu S; Gu R; Jiang X; Shen B; Zhu J; Zhang W; Pan Y; Yan J; Zhang L Front Aging Neurosci; 2022; 14():923560. PubMed ID: 36185475 [TBL] [Abstract][Full Text] [Related]
53. Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow-up. van Mierlo TJM; Foncke EMJ; Post B; Schmand BA; Bloem BR; van Harten B; Tissingh G; Munts AG; de Haan RJ; de Bie RMA; Brain Behav; 2021 Aug; 11(8):e2257. PubMed ID: 34291590 [TBL] [Abstract][Full Text] [Related]
54. Effect of interstimulus interval on visual P300 in Parkinson's disease. Wang L; Kuroiwa Y; Kamitani T; Takahashi T; Suzuki Y; Hasegawa O J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):497-503. PubMed ID: 10486398 [TBL] [Abstract][Full Text] [Related]
55. Assessment of visual misperceptions in patients with Parkinson's disease using single and bistable percepts as testing tools. Wadhwa A; Bajaj BK; Pandey S Neurol India; 2019; 67(1):123-128. PubMed ID: 30860109 [TBL] [Abstract][Full Text] [Related]